These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3965254)

  • 1. Sotalol infusion in the treatment of supraventricular tachyarrhythmias.
    Teo KK; Harte M; Horgan JH
    Chest; 1985 Jan; 87(1):113-8. PubMed ID: 3965254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy, safety, and tolerance of d-sotalol in patients with refractory supraventricular tachyarrhythmias.
    Sahar DI; Reiffel JA; Bigger JT; Squatrito A; Kidwell GA
    Am Heart J; 1989 Mar; 117(3):562-8. PubMed ID: 2919535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group.
    Sung RJ; Tan HL; Karagounis L; Hanyok JJ; Falk R; Platia E; Das G; Hardy SA
    Am Heart J; 1995 Apr; 129(4):739-48. PubMed ID: 7900626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effectiveness and safety of d,l-sotalol in the ambulatory treatment of atrial fibrillation and flutter].
    Cruz Cruz F; Iturralde Torres P; Picos Bovio E; Medeiros Domingo A; Infante Vázquez O
    Arch Inst Cardiol Mex; 1998; 68(6):482-91. PubMed ID: 10365224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter. d,l-Sotalol Atrial Fibrillation/Flutter Study Group.
    Benditt DG; Williams JH; Jin J; Deering TF; Zucker R; Browne K; Chang-Sing P; Singh BN
    Am J Cardiol; 1999 Aug; 84(3):270-7. PubMed ID: 10496434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esmolol: a new ultrashort-acting beta-adrenergic blocking agent for rapid control of heart rate in postoperative supraventricular tachyarrhythmias.
    Gray RJ; Bateman TM; Czer LS; Conklin CM; Matloff JM
    J Am Coll Cardiol; 1985 Jun; 5(6):1451-6. PubMed ID: 2860148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate.
    Deano DA; Wu D; Mautner RK; Sherman RH; Ehsani AI; Rosen KM
    Chest; 1977 May; 71(5):597-606. PubMed ID: 856558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of short intravenous amiodarone in supraventricular tachyarrhythmias.
    Vietti-Ramus G; Veglio F; Marchisio U; Burzio P; Latini R
    Int J Cardiol; 1992 Apr; 35(1):77-85. PubMed ID: 1563883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias.
    Boudonas G; Lefkos N; Efthymiadis AP; Styliadis IG; Tsapas G
    Acta Cardiol; 1995; 50(2):125-34. PubMed ID: 7610735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports.
    Faber TS; Zehender M; Van de Loo A; Hohnloser S; Just H
    Clin Cardiol; 1994 Apr; 17(4):197-202. PubMed ID: 8187370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of intravenous disopyramide for the conversion of supraventricular tachyarrhythmias.
    Stewart DE; Ikram H
    N Z Med J; 1984 Mar; 97(751):148-50. PubMed ID: 6584758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of oral sotalol during both sinus rhythm and atrial fibrillation.
    Alboni P; Razzolini R; Scarfò S; Paparella N; Fucà G; Pedini I; Chioin R
    J Am Coll Cardiol; 1993 Nov; 22(5):1373-7. PubMed ID: 8227794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Sotalol on clinical arrhythmias.
    Prakash R; Parmley WW; Allen HN; Matloff JM
    Am J Cardiol; 1972 Mar; 29(3):397-400. PubMed ID: 4110596
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term sotalol therapy in patients with arrhythmias.
    Simon A; Berman E
    J Clin Pharmacol; 1979; 19(8-9 Pt 2):547-56. PubMed ID: 385638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of sotalol in patients with refractory atrial fibrillation or flutter.
    Gallik DM; Kim SG; Ferrick KJ; Roth JA; Fisher JD
    Am Heart J; 1997 Aug; 134(2 Pt 1):155-60. PubMed ID: 9313591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of diltiazem in supraventricular paroxysmal tachyarrhythmias].
    De Rosa F; Feraco E; Venneri N; Boncompagni F; Curia F; Guzzo D; Plastina F
    G Ital Cardiol; 1986 Sep; 16(9):776-81. PubMed ID: 3803800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Intravenous Sotalol for Treatment of Incessant Tachyarrhythmias in Children.
    Li X; Zhang Y; Liu H; Jiang H; Ge H; Zhang Y
    Am J Cardiol; 2017 May; 119(9):1366-1370. PubMed ID: 28283175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with intravenous metoprolol in supraventricular tachyarrhythmias. A multicentre study.
    Rehnqvist N
    Ann Clin Res; 1981; 13 Suppl 30():68-72. PubMed ID: 7027895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.
    Fitton A; Sorkin EM
    Drugs; 1993 Oct; 46(4):678-719. PubMed ID: 7506652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic effects and safety of sotalol in the prevention of supraventricular arrhythmias after coronary artery bypass surgery.
    Jacquet L; Evenepoel M; Marenne F; Evrard P; Verhelst R; Dion R; Goenen M
    J Cardiothorac Vasc Anesth; 1994 Aug; 8(4):431-6. PubMed ID: 7948800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.